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Abstract: Objective: Crush syndrome (CS) is a serious medical condition characterized by
muscle cell damage resulting from pressure. CS has a high mortality, even when
patients receive fluid therapy. We examined whether administration of NaNO2-
containing fluid can improve survival in a rat model of CS.
Design: The CS model was generated by subjecting anesthetized rats to bilateral hind
limb compression with a rubber tourniquet for 5 h. Rats were then randomly divided
into six groups: (i) sham; (ii) CS with no treatment; (iii) CS with normal saline treatment;
(iv) CS with normal saline + 25 mEq/L bicarbonate treatment; and (v and vi) CS with
normal saline + 200 or 500 μmol/kg NaNO2.
Measurements and Main Results: Blood and tissue samples were collected for
histological and biochemical analyses at predetermined time points before and after
reperfusion. Ischemic compression of rat hind limbs reduced nitrite content in the
crushed muscle, and subsequent reperfusion resulted in reactive oxygen species-
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induced circulatory dysfunction and systemic inflammation. Rats treated with 200
µmol/kg NaNO2 showed increased nitric oxide (NO) levels, blood circulation, and
neoangiogenesis, decreased generation of reactive oxygen species, and suppression
of the inflammatory response, leading to complete recovery.
Conclusions: Treatment with 200 µmol/kg NaNO2 prevents muscle damage induced by
ischemia reperfusion via the protective effects of NO and suppression of systemic
inflammation, thereby increasing survival rates in CS.
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Dr. Irshad Chaudry 
Editor 
Shock: Injury, Inflammation, and Sepsis: Laboratory and Clinical 
 
Ref.: Ms. No. SHOCK-D-16-00487 
“Low-dose sodium nitrite fluid resuscitation prevents lethality from crush syndrome by 
improving nitric oxide consumption and preventing myoglobin cytotoxicity in kidney in a rat 
model” 
 
Dear Dr. Irshad Chaudry, 
 We are submitting a revised version of our manuscript. We are grateful for the opportunity to 
resubmit our manuscript, and appreciate the interest shown by you and the reviewers, as well as 
the helpful comments you have provided. 
 
In the revised version of the manuscript, we have incorporated the following corrections 
(marked in yellow highlight in the manuscript). 
(1) We modified the Introduction to add a more detailed discussion of why parameters 
such as MPO and lung and kidney function were assessed in this study, as suggested 
by Reviewer #1.  
(2) In the Materials and methods section, we have clarified how passenger blood was 
removed from the muscle samples, as suggested by Reviewer #1. 
(3) We modified the figures to include larger microphotographs of tissue sections in 
response to comments by Reviewers #2 and 3 that these were too small. 
(4) The figures and figure legends have been modified in accordance with the 
suggestions made by all reviewers. 
(5) We have addressed other possible antioxidative effects and HO-1 expression in the 
Discussion, as suggested by Reviewers #2 and 3. 
 
A “Response to Reviewers”, addressing the issues raised by all reviewers in detail, is 
included below.  
 
We thank you and the reviewers again for considering our work, and hope that this revision 
adequately addresses all of your concerns and questions. We look forward to hearing from you. 
 
Yours sincerely, 
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Running head 
The effects of low-dose sodium nitrite fluid resuscitation on crush syndrome 
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Abstract 
Objective: Crush syndrome (CS) is a serious medical condition characterized by muscle cell 
damage resulting from pressure. CS has a high mortality, even when patients receive fluid 
therapy. We examined whether administration of NaNO2-containing fluid can improve 
survival in a rat model of CS. 
Design: The CS model was generated by subjecting anesthetized rats to bilateral hind limb 
compression with a rubber tourniquet for 5 h. Rats were then randomly divided into six 
groups: (i) sham; (ii) CS with no treatment; (iii) CS with normal saline treatment; (iv) CS 
with normal saline + 25 mEq/L bicarbonate treatment; and (v and vi) CS with normal saline + 
200 or 500 μmol/kg NaNO2. 
Measurements and Main Results: Blood and tissue samples were collected for histological 
and biochemical analyses at predetermined time points before and after reperfusion. Ischemic 
compression of rat hind limbs reduced nitrite content in the crushed muscle, and subsequent 
reperfusion resulted in reactive oxygen species-induced circulatory dysfunction and systemic 
inflammation. Rats treated with 200 µmol/kg NaNO2 showed increased nitric oxide (NO) 
levels, blood circulation, and neoangiogenesis, decreased generation of reactive oxygen 
species, and suppression of the inflammatory response, leading to complete recovery. 
Conclusions: Treatment with 200 µmol/kg NaNO2 prevents muscle damage induced by 
ischemia reperfusion via the protective effects of NO and suppression of systemic 
inflammation, thereby increasing survival rates in CS. 
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Introduction 
Crush syndrome (CS) is a serious medical condition resulting from physical trauma obtained 
during events such as earthquakes, landslides, and traffic accidents, that is characterized by 
circulatory shock, kidney failure, and systemic inflammation (1, 2), and is associated with 
high mortality rates, especially in the acute phase. CS develops after decompression of limb 
muscles (reperfusion) following prolonged compression (ischemia) of a large proportion of 
skeletal muscle, resulting in rhabdomyolysis (muscle cell breakdown). However, CS has not 
only local effects but can also cause systemic failure resulting from acute respiratory distress 
and systemic inflammatory response syndromes, multiple organ failure, and confounding 
late-phase symptoms (3). 
Fluid therapy is the first-line treatment for CS; shock and acute kidney failure can be 
prevented by early provision of fluid. Electrolyte abnormalities are common in patients with 
crush-related acute kidney failure, with fatal hyperkalemia being the most severe case for 
which treatment with normal saline containing sodium bicarbonate is recommended (4). 
In addition to studies and clinical reports describing renal dysfunction caused by crushed 
muscle, CS can also cause a systemic inflammatory response that can lead to damage in more 
distant organs such as the lung (3,5). We previously developed a rat model of severe CS (6) 
and reported that effective rapid phleboclysis consisting of a single injection of sodium nitrite 
(NaNO2) improved survival by enhancing the recovery of muscle tissue nitrite (NO2
－) levels 
and increasing myeloperoxidase (MPO) activity in both the muscle and the lung (7). NaNO2 
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is thought to enhance kidney function and reduce systemic inflammation by increasing nitric 
oxide (NO) recovery. However, doses of 200 and 500 µmol/kg can also induce vasodilation 
and methemoglobinemia. We hypothesized that side effects could be avoided by continuous 
infusion of NaNO2-containing fluid. Our results demonstrate that intravenous administration 
of NO2
− is an effective first-line fluid therapy for treating CS.  
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Materials and methods 
Animal model of CS 
Male Wistar rats weighing 250–300 g were obtained from Japan SLC (Shizuoka, Japan) and 
housed in a room maintained at a temperature of 23°C ± 3°C and a relative humidity of 55% 
± 15% on a 12:12-h light/dark cycle, with free access to food and water. Animal experiments 
were carried out according to the guidelines for animal use, and were approved by the Life 
Science Research Center of Josai University (approval nos. H24065 and H25012). Anesthesia 
was induced by intraperitoneal injection of sodium pentobarbital (50 mg/kg body weight). 
Body temperature was maintained throughout the experiment using a heating pad. The CS 
model was established as previously reported (6). Briefly, a rubber tourniquet was applied to 
the bilateral hindlimb of each rat and wrapped five times around a 2-kg metal cylinder; the 
end of the band was glued. After a given period of time, compression was released by cutting 
the band and removing the tourniquet. 
 
Experimental design 
Animals were randomly divided into six groups: (i) sham; (ii) CS with no treatment (CS 
only group); (iii) CS with normal saline treatment (S group); (iv) CS with normal saline + 25 
mEq/l bicarbonate treatment (SB group); and (v and vi) CS with normal saline + different 
doses of NaNO2 salt (200 or 500 μmol/kg NaNO2; Wako Pure Chemical Industries, Osaka, 
Japan) (S-200N and S-500N groups, respectively). Groups iii–vi were subjected to 
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8 
compression with the rubber tourniquet, followed by 3 h of reperfusion by massive fluid 
resuscitation at a rate of 30 mL/kg/h. 
 
Analysis of mean arterial pressure, blood gas levels, biochemical parameters, coagulation, 
and nitrogen oxide and interleukin levels 
Mean arterial pressure (MAP) was determined using a Softron device (Softron Co., Tokyo, 
Japan). Blood samples from each group were obtained 1, 3, 6, and 24 h after reperfusion. The 
pH, partial pressure of oxygen (O2) and carbon dioxide (CO2), bicarbonate (HCO3
−) 
concentration, and base excess of arterial blood drawn from the femoral artery were analyzed 
using an i-STAT300F blood gas analyzer (FUSO Pharmaceutical Industries, Osaka, Japan). 
Venous blood from the postcaval vein was collected and centrifuged to measure plasma levels 
of potassium (K+), blood urea nitrogen (BUN), creatinine (Cre), and creatine phosphokinase 
(CPK) (measurements were carried out by SRL Inc., Tokyo, Japan). Methemoglobin 
(Met-Hb) was measured as previously described (7). Platelets were measured using a Celltac 
hematology analyzer (Nihon Kohden Co., Tokyo, Japan), and the levels of von Willebrand 
factor (vWF) were measured using a rat vWF enzyme-linked immunosorbent assay (ELISA) 
kit (USCN, Houston, TX, USA). Nitrite (NO2
−) concentrations in muscle and plasma were 
measured with CII and FX NO2
−/nitrate (NO3
−) assay kits (Dojindo Laboratories, Tokyo, 
Japan) according to the manufacturer’s instructions. Plasma levels of interleukin (IL)-6 and 
-10 were measured using ELISA kits (Pierce Biotechnology, Rockford, IL, USA) according 
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to the manufacturer’s instructions. 
 
Assessment of kidney function 
The bladder was cannulated in parallel to the jugular vein with PE-50 tubing. Urine samples 
were obtained from 1 h prior to decompression until immediately after decompression (0 h). 
Urine samples were collected every hour for 24 h and centrifuged at 1500 × g for 5 min at 
room temperature. Kidney function was determined based on glomerular filtration rate (GFR), 
urine volume, urine osmotic pressure (Osmomat 030-D; Gonotec GmbH, Berlin, Germany), 
N-acetyl-β-D-glucosaminidase (NAG) level (Shionogi & Co., Osaka, Japan), and urine pH 
(Pretest 5bII; Wako Pure Chemical Industries). 
 
Determination of reactive oxygen species production and MPO activity 
Reactive oxygen species (ROS) production in the injured gastrocnemius muscle was 
determined by measuring the concentration of thiobarbituric acid-reactive substances 
(TBARS). MPO activity in the muscle tissue was measured as previously described (6). For 
histological evaluations, tissue samples were fixed in 10% formalin and embedded in paraffin, 
and sections were cut and stained with hematoxylin and eosin (H&E), elastic Van Gieson 
(EVG), and anti-vWF antibody (Agilent Technologies, CA, USA). Microphotographs of the 
tissue sections were then evaluated by a pathologist (New Histo Science Laboratory, Tokyo, 
Japan). Blood was removed from the sampled tissues by the continuous infusion of phosphate 
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10 
buffer solution through the heart. 
 
Western blotting 
Western blotting was carried out as previously described (8). Briefly, rat muscle tissue was 
homogenized and centrifuged, and proteins in the lysate were separated by sodium dodecyl 
sulfate polyacrylamide gel electrophoresis using antibodies against inducible NO synthase 
(iNOS; Cell Signaling Technology, Tokyo, Japan), heme oxygenase (HO)-1 (Thermo Fisher 
Scientific K.K., Kanagawa, Japan), and α-tubulin (Cell Signaling Technology). Protein bands 
were visualized with an enhanced chemiluminescence detection system (SuperSignal West 
Dura Extended Duration Substrate; Pierce Biotechnology) with horseradish 
peroxidase-conjugated secondary antibodies (Pierce Biotechnology). Band intensity was 
quantified using ChemiDoc XRS+ Molecular Imager with Image Lab software (Bio-Rad 
Laboratories, Hercules, CA, USA), with α-tubulin used as a loading control. 
 
Statistical analysis 
Results are the average of three independent experiments and are expressed as mean ± SEM. 
Differences between groups were assessed by analysis of variance (ANOVA), with post-hoc 
analysis using Tukey’s Honest Significant Difference test (also known as Tukey’s test). 
Survival curves were generated using the Kaplan-Meier method, and survival was compared 
with the log-rank test. Differences were considered significant for P values < 0.05.  
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Results 
NaNO2 treatment improves Met-Hb and blood gas levels and MAP 
NO2
− is reduced to NO in vivo; NO accumulation can lead to methemoglobinemia and 
reduced blood pressure. We measured the effect of NaNO2 concentration (200 and 500 
µmol/kg) on Met-Hb and blood gas levels and MAP in CS rats until reperfusion at 24 h. 
During fluid resuscitation, MAP was similar between the S-500N and CS only groups; 
however, there was no change in MAP in the S-200N group throughout the experiment 
(Supplemental Digital Content Table 1). Blood gas parameters relative to the CS only group 
were improved in the S-200N and S-500N groups, but were largely unchanged in the S group 
(Supplemental Digital Content Tables 2 and 3). Oxygen saturation was within the normal 
range in all experimental groups (data not shown). Thus, treatment with 500 µmol/kg NaNO2 
increased Met-Hb, decreased MAP, and negatively affected blood gas parameters. We 
therefore excluded the S-500N group in subsequent experiments. 
 
NaNO2 treatment improves kidney function in CS 
Plasma Cre and BUN levels were higher in the CS only as compared to the sham group, but 
were lower in the S-200N than in the CS only group after 3 and 24 h of reperfusion (Figure 
1A, B). GFR as well as urine volume and osmolality were lower in the CS only than in the 
sham group, but were higher in the SB and S-200N groups than in the CS only and S groups 
(Figure 1C–E). NAG level in the distal convoluted tubule was higher in the CS only group 
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than in the sham group, and was reduced by S-200N treatment relative to the CS only group 
(Figure 1F). 
Acute kidney injury in CS is characterized by acute tubular necrosis, formation of a 
myoglobin cast, and dilation of distal convoluted tubules followed by myoglobinuric 
nephropathy. The CS only and S groups showed moderate pathological dilation of distal 
convoluted tubules; this was improved in the SB and S-200N groups after 24 h of reperfusion 
(Figure 1G). Myoglobinuric kidney failure in CS develops as a result of myoglobinuria as 
well as low urine pH. Here we found that urine pH was lower in the CS only than in the sham 
group after 24 h of reperfusion (6.0 ± 0.0 vs. 5.0 ± 0.0; P < 0.05), whereas the S and CS only 
groups showed similar values (5.0 ± 0.0 vs. 5.0 ± 0.0). However, pH was increased in the SB 
and S-200N groups relative to the CS only group (6.0 ± 0.0 and 6.5 ± 0.2 vs. 5.0 ± 0.0, 
respectively; P < 0.05). 
 
Muscle tissue injury is reversed by NaNO2 treatment 
NO2
− concentrations in injured muscle were lower in the CS only, S, and SB groups after 3 
h of reperfusion, but higher after 24 h of reperfusion, than in the sham group (Figure 2A). 
Conversely, NO3
− concentrations in injured muscle were higher in the CS only and S-200N 
groups after 3 h of reperfusion, but lower after 24 h of reperfusion, than in the sham group 
(Figure 2B). Moreover, TBARS, MPO activity, and iNOS and HO-1 expression were 
increased in the CS only and S groups relative to the sham group (Figure 2C–F). The CS only 
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group had higher plasma CPK, K+, NO2
−, and NO3
− levels than the sham group, indicating 
hyperkalemia leading to muscle cell destruction (Supplemental Digital Content Figure 1A, B). 
The CS only group showed moderate edema and neutrophil infiltration into injured muscle as 
compared to the sham group (data not shown). 
NO2
− concentrations in injured muscles were similar in the S-200N and sham groups 
(Figure 2A). However, plasma NO2
− concentrations were significantly higher in the S-200N 
group than in the CS only, S, SB, and sham groups at 3 h, but by 24 h the S-200N group 
concentration had reduced to the level of the sham group. Conversly, plasma NO3
− 
concentrations in the S-200N group were substantially higher than in the sham group at both 
3 and 24 h, with no reduction over time (Supplemental Digital Content Figure 1C, D). 
TBARS, MPO activity, and iNOS and HO-1 expression were lower in the sham and S-200N 
groups than in the CS only group, but comparable levels were seen in the CS only group and 
the S and SB groups (Figure 2). Fluid resuscitation (i.e., S, SB, and S-200N groups) 
worsened edema relative to the sham and CS only groups after 3 h of reperfusion, resulting in 
moderate edema; however, the degree of edema was similar in the S-200N and sham groups 
at 24 h (Supplemental Digital Content Figure 2A, B). Moreover, neutrophil infiltration was 
reduced in the S-200N as compared to the CS only, S, and SB groups at 24 h (Supplemental 
Digital Content Figure 2, B). We observed that vascular endothelial cell staining in the 
S-200N group was more prominent than in the CS only group (Supplemental Digital Content 
Figure 2D). 
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Lung tissue injury in CS is mitigated by NaNO2 treatment 
There were no pathological changes in any of the experimental groups after reperfusion for 
3 h; however, the CS only group showed moderate alveolar edema and neutrophil infiltration 
at 24 h (Figure 3A), which was associated with an increase in lung tissue MPO activity 
(Figure 3B). S-200N treatment reduced the area of damage and degree of injury to the 
alveolar lumen structure as well as alveolar hemorrhage compared to the CS only group after 
24 h of reperfusion (Figure 3A), with a corresponding reduction in lung tissue MPO activity 
(Figure 3B). Additionally, plasma concentrations of the proinflammatory cytokines IL-6 and 
-10 were higher in the CS only as compared to the sham group at 3 and 24 h of reperfusion 
(Figure 3C-D). 
 
NaNO2 treatment mitigates endothelial damage and coagulation 
Levels of plasma vWF, platelets, and fibrinogen were measured in order to assess 
endothelial damage and coagulation resulting from crush injury (Figure 4). Plasma vWF level 
was higher in the CS only as compared to the sham group, whereas levels were lower in the 
S-200N than in the CS only, S, and SB groups (Figure 4A). Plasma platelet and fibrinogen 
levels were lower after 24 h in the CS only group relative to the sham group; however, this 
trend was reversed by fluid resuscitation (Figure 4B, C). 
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NaNO2 treatment increases survival rates after CS 
As expected, 100% of the mice in the sham group survived for at least 48 h after reperfusion. 
The survival rate of rats in the CS only group decreased over time to 85%, 55%, 35%, and 
35% at 3, 6, 24, and 48 h after reperfusion, respectively. A similar trend was observed in the S 
group. The SB group showed a higher survival rate than the CS and S groups up to 48 h after 
reperfusion. Unexpectedly, NaNO2 treatment resulted in a 100% survival rate over the 48 h 
experimental period in the S-200N group (Figure 5).  
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Discussion 
Up to 20% of deaths after major earthquakes occur shortly after extrication (9) and are 
usually due to crush injury; this can be aggravated by extra-renal complications (infections or 
pulmonary, cardiovascular, hematological, gastrointestinal, neurological, or psychiatric 
problems), which can increase morbidity and mortality (10–11). On-site CS therapy can 
improve the probability of survival; it is recommended that normal saline (1000 mL/h for 
adults) be administered to prevent acute kidney malfunction. In this study, we administered 
fluid at a rate of 30 mL/kg/h to examine the effect of NaNO2 on survival rate, followed by 
rates of 10, 20, and 30 mL/kg/h. 
The optimal dosage of NO2
− required for a protective effect was 48–480 µmol (in tissue) or 
10–200 nM (in blood) (12). Previous studies reported dosages of 10 or 50 µM and 0.2 
µmol/min/kg (13, 14). We found that 500 µmol NaNO2 could negatively affect CS symptoms. 
In contrast, a dosage of 200 µmol NaNO2 (i.e. S-200N group) was within the NO2
− 
concentration range in injured muscle tissue (47±21 to 56±21 nmol/g tissue, Figure 2A) 
and plasma (5.1±5.4 to 29.2±30.9 µM, Supplemental Digital Content Figure 1C) at 3 and 
24 h, and did not have adverse effects. 
Renal failure is a serious complication of CS that can result from circulatory shock, renal 
afferent arteriolar vasoconstriction (urinary concentration), increased urinary myoglobin 
levels, or metabolic acidosis (urinary acidity) (15–17), all of which can cause precipitation in 
distal convoluted tubules and tubular cast formation with subsequent tubular obstruction. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
17 
Myoglobin accumulation has also been shown to cause oxidant injury (18, 19). In these cases, 
renal replacement therapy can improve patient survival. 
Normal and bicarbonate-containing saline are recommended as fluids for preventing 
hyperkalemia and circulatory shock associated with CS. Moreover, maintaining urinary pH 
above 6.5 can prevent intratubular deposition of myoglobin (20). NO has been shown to 
increase urinary flow (21). In the present study, the S-200N group showed an improvement in 
GFR and urinary pH and volume relative to the CS only group, indicating that treatment with 
200 μmol/kg NaNO2 protected against renal failure in CS. Interestingly, NAG level in renal 
tubules, a marker of cytotoxicity, was normalized in the S-200N as compared to the CS only 
group. NO is a free radical scavenger that binds strongly to iron in hemoglobin and 
myoglobin. Moreover, Kanner et al. reported than NO prevented the initiation of lipid 
peroxidation by ROS and myoglobin (22) The NO2
− concentration administered in this study 
was higher than endogenous levels; it is possible that NO2
−-derived NO suppressed free 
radicals bound to myoglobin in urine. 
The principal findings of this study are that resuscitation from CS using NaNO2-containing 
fluid can improve systemic and microvascular hemodynamics. The importance of exogenous 
NO2
− administration under anemic, hypoxic, and hypovolemic conditions is evidenced by the 
resultant decrease in vascular resistance and increase in perivascular perfusion. Restoration of 
blood pressure with incomplete recovery of perfusion after resuscitation prevents 
microvascular collapse. Low-dose NO2
− supplementation after fluid resuscitation improved 
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microvascular perfusion via peripheral vasodilation without decreasing blood pressure. NO 
production was demonstrated by the decrease in NO2
− concentration in the early phase of 
reperfusion in injured muscle. Under ischemic (low-oxygen) conditions, mitochondrial 
dysfunction results in ROS generation. NO protects mitochondria by acting as an oxygen 
radical scavenger (23). Furthermore, NO promotes antioxidation through the induction of 
superoxide dismutase (24). HO-1 induction is known to be protective following injury, 
however in this study, while HO-1 expression was higher in the CS only group than in the 
sham control group; it was significantly reduced by S-200N treatment. This suggests that 
nitrite-containing fluid resuscitation prevented oxidative damage and thus the induction of 
HO-1, and therefore offers protection independently from HO-1 expression. The overall 
protection provided by NO2
− (i.e., hypoxia-induced mitochondrial ROS production and blood 
coagulation) depends on soluble guanylyl cyclase signaling (25, 26). NO is an important 
regulatory factor that inhibits leukocyte adhesion (27), expression of intercellular adhesion 
molecule and p-selectin (28), and plasma vWF levels (29). We propose that NO may prevent 
excessive damage resulting from inflammation and promote the recovery of muscle cells 
following crush injury. 
 Interestingly, fluid containing NaNO2 induced neoangiogenesis and does not increase red 
blood cell (RBC) counts after crush injury. The decrease in blood circulation stimulated RBC 
production, as indicated by hematocrit level in the CS only group, which increased for 24 h of 
reperfusion. However, administration of NaNO2-containing fluid produced similar results to 
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those observed in the sham group. NaNO2 is a highly stable compound that releases NO only 
under conditions of ischemia, hypoxia, or low pH; as such, cardiovascular therapy with NO2
− 
could be targeted to ischemic or hypoxic tissues, thereby reducing the risk of systemic 
hypotension (30). Exogenous NO2
− can increase perfusion when administered after fluid 
resuscitation following hemorrhagic shock, underscoring its potential as a therapeutic agent 
(31, 32). During the stanching process, the injured vascular endothelial cells produce vWF, 
causing them to interact with platelets. Using immunostaining to detect and visualize vWF, 
and thus the vascular endothelial cell network, the degree of neoangiogenesis can be 
evaluated. We observed that the vascular endothelial damage seen in the S-200N group was 
less pronounced than in the CS only group (Supplemental Digital Content Figure 2D). We 
suggest that increasing endogenous NO enhances not only oxygen delivery but also the 
induction of neoangiogenesis, while decreasing shear stress via a modest vasodilatory effect 
(33–35) (Supplemental Digital Content Table 5 and Figure 2). 
In conclusion, administration of NaNO2 can lead to a dramatic improvement in survival 
following CS owing to the anti-oxidative, anti-coagulant, and anti-inflammatory effects of 
NO2
− acting as a NO donor in hypoxic/acidified organs.  
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Figure legends 
Figure 1. Effect of fluid resuscitation on kidney function in CS rats. 
(A) BUN concentration, (B) Cre concentration, (C) GFR, (D) urine volume, (E) urine 
osmotic pressure, (F) NAG concentration, and (G) hematoxylin and eosin-stained kidney 
sections following reperfusion for 3 and 24 h. White bar, sham; black bar, CS only; gray bar, 
S; diagonal bar, SB; shaded bar, S-200N. Values represent mean ± SEM (n = 3). #P < 0.05 vs. 
sham group, *P < 0.05 vs. CS only group; †P < 0.05 vs. S group, ‡P < 0.05 vs. SB group 
(Tukey’s test). Micrographs are representative of three independent experiments (200× 
magnification; scale bars = 100 μm). Black arrowhead: dilated kidney tubule. 
 
Figure 2. Effect of fluid resuscitation on NO2−, NO3−, and TBARS levels, MPO activity, 
and iNOS and HO-1 expression in muscle tissue of CS rats. 
(A) muscle NO2
− level, (B) muscle NO3
− level, (C) muscle TBARS, (D) muscle MPO activity, 
(E) iNOS/α-tubulin ratio, and (F) HO-1/α-tubulin ratio following 3 and 24 h of reperfusion. 
White bar, sham; black bar, CS only; gray bar, S; diagonal bar, SB; shaded bar, S-200N. 
Values represent mean ± SEM (n = 3). #P < 0.05 vs. sham group, *P < 0.05 vs. CS only 
group; †P < 0.05 vs. S group, ‡P < 0.05 vs. SB group (Tukey’s test). 
iNOS and HO-1 expression is shown relative to that of the sham group. 
 
Figure 3. Effect of fluid resuscitation on lung injury and distant organs in CS rats. 
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(A) Hematoxylin and eosin-stained lung tissue sections. (B) lung MPO activity, (C) plasma 
IL-6 concentration, and (D) plasma IL-10 concentration following 3 and 24 h of reperfusion. 
White bar, sham; black bar, CS only; gray bar, S; diagonal bar, SB; shaded bar, S-200N. 
Values represent mean ± SEM (n = 3). #P < 0.05 vs. sham group, *P < 0.05 vs. CS only 
group; †P < 0.05 vs. S group, ‡P < 0.05 vs. SB group (Tukey’s test). Micrographs are 
representative of three independent experiments (400× magnification; scale bars = 200 μm). 
Black arrowhead: neutrophil. 
 
Figure 4. Effect of fluid resuscitation on blood coagulation, vWF level, platelet count, 
and fibrinogen expression in CS rats. 
(A) Plasma vWF, (B) platelet, and (C) fibrinogen levels following 3 and 24 h of reperfusion. 
White bar, sham; black bar, CS only; gray bar, S; diagonal bar, SB; shaded bar, S-200N. 
Values represent mean ± SEM (n = 3). #P < 0.05 vs. sham group, *P < 0.05 vs. CS only 
group; †P < 0.05 vs. S group, ‡P < 0.05 vs. SB group (Tukey’s test). 
Fibrinogen levels are shown relative to those of the sham group. 
  
Figure 5. Cumulative survival in CS rats in the 48 h after reperfusion. 
Survival rates from 0 to 48 h after reperfusion. Open circle, sham (n = 10); closed circle, CS 
only (n = 20); open square, S (n = 10); open diamond, SB (n = 10); closed square, S-200N (n 
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= 10). #P < 0.05 vs. sham group; *P < 0.05 vs. CS only group; †P < 0.05 vs. S group. Survival 
curves were generated by the Kaplan-Meier method and compared using the log-rank test.  
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Supplemental Digital Content Figure 1. Effect of fluid resuscitation on plasma NO2−, 
NO3−, CPK, and K+ levels in CS rats. 
(A) plasma CPK, (B) plasma K+, (C) plasma NO2
−, and (D) plasma NO3
− levels from after 3 
and 24 h of reperfusion. White bar, sham; black bar, CS only; gray bar, S; diagonal bar, SB; 
shaded bar, S-200N. Values represent mean ± SEM (n = 3). #P < 0.05 vs. sham group; *P < 
0.05 vs. CS only group; †P < 0.05 vs. S group, ‡P < 0.05 vs. SB group (Tukey’s test). 
 
Supplemental Digital Content Figure 2. Effect of fluid resuscitation on muscle tissue 
architecture in crush-injured muscle, as determined by H&E, EVG, and vWF staining. 
(A) H&E-stained section of muscle reperfused for 3 h. (B) H&E-, (C) EVG-, and (D) 
vWF-stained muscle tissue sections after 24 h of reperfusion. Micrographs are representative 
of three independent experiments (400× magnification; scale bars = 200 μm). Black 
arrowhead: neutrophil; white arrowhead: hemorrhage; gray arrowhead: neoangiogenesis.  
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